Filing Details

Accession Number:
0001385508-19-000054
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-06-04 16:21:20
Reporting Period:
2019-06-03
Accepted Time:
2019-06-04 16:21:20
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1385508 Opiant Pharmaceuticals Inc. OPNT () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1358116 Phil Skolnick C/O Opiant Pharmaceuticals, Inc.
201 Santa Monica Blvd., Suite 500
Santa Monica CA 90401
Chief Scientific Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-06-03 10,000 $9.00 10,000 No 4 M Direct
Common Stock Disposition 2019-06-03 8,414 $11.72 1,586 No 4 S Direct
Common Stock Disposition 2019-06-04 1,586 $11.63 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2019-06-03 10,000 $0.00 10,000 $9.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
110,000 2018-08-06 2027-02-06 No 4 M Direct
Footnotes
  1. The option was exercised pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person.
  2. The shares were sold pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person.